US Patent 7423157 Substituted benzimidazoles and their use for inducing apoptosis
Patent 7423157 was granted and assigned to Basilea Pharmaceutica on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Alessandro Strebel0
Felix Bachmann0
Goutam Saha0
Martin Eberle0
Subho Roy0
Sudhir Srivastava0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+64 characters)
Article
Patent abstract
The invention relates to compounds of formula (I)
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07423157 Substituted benzimidazoles and their use for inducing apoptosis US Patent 7423157 Substituted benzimidazoles and their use for inducing apoptosis
Infobox
Patent Number
074231570
Patent Number
74231570
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074231570
Date of Patent
September 9, 2008
0Patent Application Number
115016480
Date Filed
August 9, 2006
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07423157 Substituted benzimidazoles and their use for inducing apoptosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07423157
Date of patent
September 9, 2008
Patent application number
11501648
Date Filed
August 9, 2006
Patent primary examiner
Find more entities like US Patent 7423157 Substituted benzimidazoles and their use for inducing apoptosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
